Brief: iTeos Reports Fourth Quarter Results, Provides Business Updates

iTeos Therapeutics

15/03/2023 12:04

March 15 (Reuters) - Iteos Therapeutics Inc  ITOS.O :
    * ITEOS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
    * CASH AND INVESTMENT BALANCE OF $731.4MM AS OF DECEMBER 31,
2022,
EXPECTED TO PROVIDE RUNWAY INTO 2026
    * ITEOS THERAPEUTICS - EOS-984, PROGRAM TARGETING A NEW
MECHANISM
OF ACTION IN ADENOSINE PATHWAY, EXPECTED TO ENTER CLINICAL
STUDIES IN MID-2023
    * CASH, CASH EQUIVALENTS AND INVESTMENTS POSITION WAS $731.4
MILLION AS OF DECEMBER 31, 2022
    * QTRLY EPS $0.54
    * Q4 EARNINGS PER SHARE VIEW $0.33 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX54sZqG 
Further company coverage:  ITOS.O